William E. Klitgaard - 25 May 2023 Form 4 Insider Report for Syneos Health, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 25 May 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 May 2023, 17:15:55 UTC
Prior SEC filing: 18 Oct 2022
Next SEC filing: 28 Sep 2023
Source filing: View source filing
Reporting owner signature: /s/ Sara Epstein, Attorney-in-Fact

Key filing fact

William E. Klitgaard filed Form 4 for Syneos Health, Inc. on 30 May 2023.

Key facts

This page summarizes William E. Klitgaard's Form 4 filing for Syneos Health, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 30 May 2023, 17:15.

Change

Previous filing in this sequence was filed on 18 Oct 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SYNH transaction

Class A Common Stock

Award

Transaction value: $0
Shares: +4,863
Change %: +194%
Price: $0.000000
Shares after: 7,370
Date: 25 May 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents an award of restricted stock units that vests in full one year from the grant date, or, if earlier, the date of the 2024 annual meeting of stockholders but only to the extent the director is not re-elected as a non-employee director at such annual meeting, in each case, subject to continued service on the Issuer's Board of Directors.